Sorry 600 procedures should be $1.35 mill so,it seems a further $600k is outstanding which agrees with admedus $2.5 mill rev. This does seem to be in line with exponential growth and needs to be confirmed either by the next 4c or admedus themselves. As I said it does take some finding.
- Forums
- ASX - By Stock
- AVR
- Quarterly
Quarterly, page-90
-
-
- There are more pages in this discussion • 85 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add AVR (ASX) to my watchlist
|
|||||
Last
$17.79 |
Change
-0.120(0.67%) |
Mkt cap ! $347.9M |
Open | High | Low | Value | Volume |
$18.00 | $18.10 | $17.79 | $30.95K | 1.724K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 26 | $17.72 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$17.90 | 76 | 3 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 26 | 17.720 |
1 | 640 | 17.710 |
1 | 443 | 17.700 |
1 | 93 | 17.660 |
2 | 276 | 17.650 |
Price($) | Vol. | No. |
---|---|---|
17.900 | 76 | 3 |
17.940 | 177 | 1 |
17.950 | 200 | 1 |
18.140 | 45 | 1 |
18.240 | 500 | 1 |
Last trade - 11.28am 16/07/2024 (20 minute delay) ? |
Featured News
AVR (ASX) Chart |
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online